GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
(Reupload).png)
.png)
Technology:
Small Molecules
Industry:
Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2017
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership